drugset / Trial / NCT02557503

Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

NCT02557503

Phase 4 Unknown 110 enrolled Zhu Xu
RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate the therapy effect and security of oxaliplatin and fluorouracil on with or without concomitant vascular invasion and extrahepatic metastases unresectable advanced primary liver cancer

Timeline

Start
2015-01
Primary completion
2016-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule Other
Subject fluorouracil Small molecule Other

Indications